AbCellera Biologics Inc.

NASDAQ (USD): AbCellera Biologics Inc. (ABCL)

Last Price

2.72

Today's Change

-0.17 (5.88%)

Day's Change

2.50 - 2.79

Trading Volume

3,818,520

Overview

Market Cap

801 Million

Shares Outstanding

294 Million

Avg Volume

1,924,168

Avg Price (50 Days)

2.63

Avg Price (200 Days)

3.61

PE Ratio

-5.13

EPS

-0.53

Earnings Announcement

04-Nov-2024

Previous Close

2.89

Open

2.50

Day's Range

2.5 - 2.79

Year Range

2.335 - 6.055

Trading Volume

3,818,699

Price Change Highlight

1 Day Change

-5.88%

5 Day Change

-1.45%

1 Month Change

8.80%

3 Month Change

-1.45%

6 Month Change

-32.51%

Ytd Change

-52.53%

1 Year Change

-39.22%

3 Year Change

-81.97%

5 Year Change

-95.38%

10 Year Change

-95.38%

Max Change

-95.38%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment